Abdi Khalif
Automation engineer and operator at the intersection of genomics, clinical diagnostics, and software.
Experience
Leading a software-focused team that integrates lab systems with LIMS, develops custom tooling, and builds fully integrated monitoring systems for clinical laboratory operations.
Freenome develops blood-based tests for early cancer detection. Its SimpleScreen CRC colorectal cancer screen is under FDA review with approval anticipated mid-2026, and the company is set to go public via a $330M SPAC deal later this year.
One of the first two lab hires (~employee #15). Part of team that built and validated Color's CAP/CLIA-certified clinical laboratory, launching a 19-gene hereditary cancer panel — including BRCA1 and BRCA2 — at a groundbreaking $249.
Validated and tested new liquid biopsy panels for cancer detection.